Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.

Aliyev, A; Demir, T; Coban, E; Seker, MESUT; Celik, RS; Turk, HM; Kocyigit, A; Baydas, T

Date

2019-07-29

Author

Aliyev, A
Demir, T
Coban, E
Seker, MESUT
Celik, RS
Turk, HM
Kocyigit, A
Baydas, T

Advisor

Type

Article

Metadata

Show full item record

Abstract

Objective: M30 and M65 levels reflect tumor cell activity in patients with epithelial cancer. Cytokeratin 18 is one of the cell skeletal elements. M30 is a apoptotic marker of cytokeratin 18. M65 levels are both an apoptosis and a necrosis marker. The aim of our study was to determine the predictive value of M30 and M65 levels in neoadjuvant treatment of breast cancer.